ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,406, issued on Feb. 24, was assigned to MEDIMABBIO INC. (Seongnam-si, South Korea).
"Anti-TIGIT antibodies and use thereof" was invented by Yuhoi Kang (Seongnam-si, South Korea) and Hongseok Jo (Hwaseong-si, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to: novel anti-TIGIT antibodies; and uses thereof for increasing immunity, anticancer treatments, and preventing and/or treating immunological diseases."
The patent was filed on May 10, 2022, under Application No. 18/290,171.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Se...